Products for Research Use Only
RegisterLogin

Tivantinib

CAT: 0804-HY-50686-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-50686-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tivantinib is a highly selective c-Met tyrosine kinase inhibitor with a Ki of 355 nM.
CAS Number
905854-02-6
Product Name Alternative
ARQ 197; (3R,4R) -ARQ 198
UNSPSC
12352005
Hazard Statement
H360, H373
Target
Apoptosis; c-Met/HGFR
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Tivantinib.html
Purity
99.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=O)[C@@H](C2=CN3C4=C(C=CC=C42)CCC3)[C@@H]1C5=CNC6=C5C=CC=C6
Molecular Formula
C23H19N3O2
Molecular Weight
369.42
Precautions
H360, H373
References & Citations
[1]Munshi N, et al. ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity. Mol Cancer Ther. 2010 Jun;9 (6) :1544-53.|[2]Bai YL, et al. Quantitative analysis of tivantinib in rat plasma using ultra performance liquid chromatography with tandem mass spectrometry. J Pharm Biomed Anal. 2016 Jul 15;126:98-102.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3

Chemical Information

Tivantinib

LSM-1131 is a member of indoles.

CAS Number905854-02-6
PubChem CID11494412
IUPAC Name(3R,4R)-3-(1-azatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraen-3-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
Molecular FormulaC23H19N3O2
Molecular Weight369.4
XLogP2.9
Topological Polar Surface Area66.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Heavy Atom Count28
Formal Charge0
Complexity666
SMILES
C1CC2=C3C(=CC=C2)C(=CN3C1)[C@H]4[C@@H](C(=O)NC4=O)C5=CNC6=CC=CC=C65
InChI
InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1
InChIKey
UCEQXRCJXIVODC-PMACEKPBSA-N
Chemical Structure
2D Structure
2D structure of Tivantinib
CAS: 905854-02-6
CID: 11494412
Formula: C23H19N3O2
MW: 369.4
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight369.4
XLogP32.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass369.147726857
Monoisotopic Mass369.147726857
Topological Polar Surface Area66.9 Ų
Heavy Atom Count28
Formal Charge0
Complexity666
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Alternative Products

CatalogName
B1546-25Tivantinib
T83524-01(rel) -Tivantinib
MBS5825173(rel)-Tivantinib
A8325-STivantinib (ARQ 197)
MBS132509-01ARQ 197, Tivantinib
MBS5825206(3S,4S)-Tivantinib

Popular Products